UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model

Retrovirology, 2012-07, Vol.9 (1), p.56-56, Article 56

2012

Link zum Volltext

Verfügbarkeit prüfen

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

Immunology letters, 1996-06, Vol.51 (1), p.107-114

1996

Link zum Volltext

Verfügbarkeit prüfen

A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection

AIDS (London), 1998-03, Vol.12 (5), p.F15-F22

1998

Link zum Volltext

Verfügbarkeit prüfen

Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaques

Journal of general virology, 2009-04, Vol.90 (4), p.915-926, Article 915

2009

Link zum Volltext

Verfügbarkeit prüfen

Simian Immunodeficiency Virus Evades a Dominant Epitope-Specific Cytotoxic T Lymphocyte Response Through a Mutation Resulting in the Accelerated Dissociation of Viral Peptide and MHC Class I

The Journal of immunology (1950), 2000-06, Vol.164 (12), p.6474-6479

2000

Link zum Volltext

Verfügbarkeit prüfen

Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys

Journal of Virology, 1996-01, Vol.70 (1), p.678-681

1996

Link zum Volltext

Verfügbarkeit prüfen

Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys

Journal of Virology, 1996-10, Vol.70 (10), p.7335-7340

1996

Link zum Volltext

Verfügbarkeit prüfen

Cellular immune response to SIVmac and HIV-2 in macaques : model for the human HIV-1 infection

Journal of acquired immune deficiency syndromes (1988), 1993-09, Vol.6 (9), p.969-976

1993

Link zum Volltext

Verfügbarkeit prüfen

Human Immunodeficiency Virus Type 1 Envelope Glycoprotein-Specific Cytotoxic T Lymphocytes in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys

Virology (New York, N.Y.), 1995-04, Vol.208 (2), p.770-775

1995

Link zum Volltext

Verfügbarkeit prüfen

Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivo

Virology (New York, N.Y.), 1996-02, Vol.216 (2), p.444-450

1996

Link zum Volltext

Verfügbarkeit prüfen

Immunization with Tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection

Virology (New York, N.Y.), 1992-02, Vol.186 (2), p.588-596

1992

Link zum Volltext

Verfügbarkeit prüfen

Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus

AIDS (London), 1993-06, Vol.7 (6), p.787-795

1993

Link zum Volltext

Verfügbarkeit prüfen

Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130

Journal of general virology, 1993-09, Vol.74 (9), p.1757-1763

1993

Link zum Volltext

Verfügbarkeit prüfen

Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques

Journal of general virology, 1992-09, Vol.73 (9), p.2273-2281

1992

Link zum Volltext

Verfügbarkeit prüfen

Identification of a Gag Protein Epitope Conserved Among All Four Groups of Primate Immunodeficiency Viruses by Using Monoclonal Antibodies

Journal of general virology, 1992-10, Vol.73 (10), p.2721-2724

1992

Link zum Volltext

Verfügbarkeit prüfen

Antibody response to the negative regulatory factor (nef) in experimentally infected macaques: Correlation with viremia, disease progression, and seroconversion to structural viral proteins

Virology (New York, N.Y.), 1991-07, Vol.183 (1), p.267-272

1991

Link zum Volltext

Verfügbarkeit prüfen

Immunization of rhesus monkeys with high- and low-dose tween-ether-disrupted SIVMAC

AIDS research and human retroviruses, 1992-08, Vol.8 (8), p.1397-1400

1992

Link zum Volltext

Verfügbarkeit prüfen

Immunization of macaque monkeys with low- and high-dose regimens of SIVmac results in different immune responses

Immunology today (Amsterdam. Regular ed.), 1994-02, Vol.15 (2), p.90-91

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 18 von 18

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Full Collection 2018

ThemaSimian Immunodeficiency Virus - Immunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(3)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection

Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaques

Simian Immunodeficiency Virus Evades a Dominant Epitope-Specific Cytotoxic T Lymphocyte Response Through a Mutation Resulting in the Accelerated Dissociation of Viral Peptide and MHC Class I

Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys

Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys

Cellular immune response to SIVmac and HIV-2 in macaques : model for the human HIV-1 infection

Human Immunodeficiency Virus Type 1 Envelope Glycoprotein-Specific Cytotoxic T Lymphocytes in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys

Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivo

Immunization with Tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection

Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus

Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130

Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques

Identification of a Gag Protein Epitope Conserved Among All Four Groups of Primate Immunodeficiency Viruses by Using Monoclonal Antibodies

Antibody response to the negative regulatory factor (nef) in experimentally infected macaques: Correlation with viremia, disease progression, and seroconversion to structural viral proteins

Immunization of rhesus monkeys with high- and low-dose tween-ether-disrupted SIVMAC

Immunization of macaque monkeys with low- and high-dose regimens of SIVmac results in different immune responses

Aktive Filter

Suchergebnisse filtern